CUSIP: 03759B102
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,141,384
-
Share change
-
+3,051,638
-
Total reported value
-
$8,481,000
-
Put/Call ratio
-
88%
-
Price per share
-
$2.70
-
Number of holders
-
12
-
Value change
-
+$7,569,000
-
Number of buys
-
12
-
Number of sells
-
1
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 03759B102:
Institutional Holders of APEXIGEN INC - COM (APGN) as of Q3 2022
As of 30 Sep 2022,
APEXIGEN INC - COM (APGN) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,141,384 shares.
The largest 10 holders included
Decheng Capital Management III (Cayman), LLC, Yu Fan, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, and TWO SIGMA INVESTMENTS, LP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.